Viewing Study NCT00310232


Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2025-12-25 @ 7:17 PM
Study NCT ID: NCT00310232
Status: TERMINATED
Last Update Posted: 2024-04-02
First Post: 2006-03-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
Sponsor: Ontario Clinical Oncology Group (OCOG)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module